tiprankstipranks
Advertisement
Advertisement

AU:ENP Stock Latest News

Entropy Neurodynamics Issues 20 Million Unquoted Options Expiring 2029
Company AnnouncementsEntropy Neurodynamics Issues 20 Million Unquoted Options Expiring 2029
5d ago
ENP
Entropy Neurodynamics Wins Shareholder Backing for Psychedelic Therapy Push
PremiumCompany Announcements
Entropy Neurodynamics Wins Shareholder Backing for Psychedelic Therapy Push
16d ago
ENP
Entropy Neurodynamics Seeks ASX Quotation for 600,000 New Shares
PremiumCompany Announcements
Entropy Neurodynamics Seeks ASX Quotation for 600,000 New Shares
22d ago
ENP
Tryptamine-Linked Entropy Neurodynamics Director Increases Equity Stake via Off-Market Transfer
PremiumCompany Announcements
Tryptamine-Linked Entropy Neurodynamics Director Increases Equity Stake via Off-Market Transfer
25d ago
ENP
Entropy Neurodynamics Seeks ASX Quotation for 1.2 Million New Shares
PremiumCompany Announcements
Entropy Neurodynamics Seeks ASX Quotation for 1.2 Million New Shares
25d ago
ENP
Entropy Neurodynamics Fully Enrols First Cohort in IV Psilocin Binge Eating Trial
PremiumCompany AnnouncementsEntropy Neurodynamics Fully Enrols First Cohort in IV Psilocin Binge Eating Trial
1M ago
ENP
Entropy Neurodynamics Seeks ASX Quotation for 1.5 Million New Shares
Premium
Company Announcements
Entropy Neurodynamics Seeks ASX Quotation for 1.5 Million New Shares
1M ago
ENP
Entropy Neurodynamics Narrows Half-Year Loss and Lifts Asset Backing After Rebrand
Premium
Company Announcements
Entropy Neurodynamics Narrows Half-Year Loss and Lifts Asset Backing After Rebrand
1M ago
ENP
Entropy Neurodynamics Issues 2026 EGM Materials and Streamlines Investor Communications
PremiumCompany Announcements
Entropy Neurodynamics Issues 2026 EGM Materials and Streamlines Investor Communications
2M ago
ENP
Entropy Neurodynamics Director Increases Stake With On-Market Share Purchase
PremiumCompany Announcements
Entropy Neurodynamics Director Increases Stake With On-Market Share Purchase
2M ago
ENP
Tryptamine Therapeutics director ups stake with on-market share buy
PremiumCompany Announcements
Tryptamine Therapeutics director ups stake with on-market share buy
2M ago
ENP
Entropy Neurodynamics Hits Milestone in World-First IV Psilocin Trial for Binge Eating Disorder
PremiumCompany Announcements
Entropy Neurodynamics Hits Milestone in World-First IV Psilocin Trial for Binge Eating Disorder
2M ago
ENP
Entropy Neurodynamics Reports Encouraging First-Patient Data for IV Psilocin in Binge Eating Disorder Trial
PremiumCompany AnnouncementsEntropy Neurodynamics Reports Encouraging First-Patient Data for IV Psilocin in Binge Eating Disorder Trial
2M ago
ENP
Entropy Neurodynamics Issues Shares to Director in Lieu of Cash Fees
Premium
Company Announcements
Entropy Neurodynamics Issues Shares to Director in Lieu of Cash Fees
3M ago
ENP
Entropy Neurodynamics Issues Shares in Lieu of Director Fees Under Secondary Trading Provisions
Premium
Company Announcements
Entropy Neurodynamics Issues Shares in Lieu of Director Fees Under Secondary Trading Provisions
3M ago
ENP
Entropy Neurodynamics Issues Shares to Directors in Lieu of Cash Fees
PremiumCompany Announcements
Entropy Neurodynamics Issues Shares to Directors in Lieu of Cash Fees
3M ago
ENP
Entropy Neurodynamics Reports Strong Phase 2a Results for Psilocybin-Based Binge Eating Therapy
PremiumCompany Announcements
Entropy Neurodynamics Reports Strong Phase 2a Results for Psilocybin-Based Binge Eating Therapy
3M ago
ENP
Entropy Neurodynamics Grants 10 Million Director Options to Chris Ntoumenopoulos
PremiumCompany Announcements
Entropy Neurodynamics Grants 10 Million Director Options to Chris Ntoumenopoulos
4M ago
ENP
Entropy Neurodynamics Issues 2 Million Unquoted Options Expiring in 2027
PremiumCompany Announcements
Entropy Neurodynamics Issues 2 Million Unquoted Options Expiring in 2027
4M ago
ENP
Entropy Neurodynamics Issues 50 Million Unquoted Options Under Incentive Scheme
PremiumCompany AnnouncementsEntropy Neurodynamics Issues 50 Million Unquoted Options Under Incentive Scheme
4M ago
ENP
Entropy Neurodynamics Secures $847,186 R&D Tax Refund to Advance Psychedelic Therapy Trials
Premium
Company Announcements
Entropy Neurodynamics Secures $847,186 R&D Tax Refund to Advance Psychedelic Therapy Trials
4M ago
ENP
Entropy Neurodynamics Advances Binge Eating Disorder Trial with TRP-8803
Premium
Company Announcements
Entropy Neurodynamics Advances Binge Eating Disorder Trial with TRP-8803
4M ago
ENP

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >